Nevirapine pharmacokinetics with infant prophylaxis
12 May 2006. Related: Conference reports, Paediatric care.
Paediatric care
Paediatric studies at EACS: trends in antiretroviral use in the Madrid Cohort; life expectancy significantly increased HIV/HCV co-infected children since HAART; use of tenofovir in treatment experienced children; switching to lopinavir/r from double protease inhibitor regimen; once daily lopinavir/r, 3TC and abacavir; planned treatment interruptions in children
11 February 2006. Related: Conference reports, Paediatric care.
Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
10 February 2006. Related: Conference reports, Paediatric care.
US paediatric guidelines updated (Feb 2006)
8 February 2006. Related: Paediatric care, Guidelines.
Pharmacokinetics of nevirapine in HIV positive children receiving Thai fixed dose combination
13 October 2005. Related: Paediatric care.
Lopinavir/r use in children less than two years old promising results despite low plasma levels
14 September 2005. Related: Conference reports, Paediatric care.
Favourable outcomes in children treated with HAART in the MSF programmes
14 September 2005. Related: Conference reports, Paediatric care.
Encouraging results with cut up generic fixed dose combination tablets in Uganda
14 September 2005. Related: Conference reports, Paediatric care.
Predictors of survival at three years follow up for HIV-infected children in Cote D’Ivoire
14 September 2005. Related: Conference reports, Paediatric care.
Underdosing of ARVs in children: results from CHIPS cohort
15 June 2005. Related: Conference reports, Paediatric care.
Dosing nevirapine in children
15 June 2005. Related: Conference reports, Paediatric care.
Intracellular NRTI-triphosphate levels in children are similar to adults
15 June 2005. Related: Conference reports, Paediatric care.
Once-daily lopinavir/ritonavir for children may offer advantages
15 May 2005. Related: Conference reports, Paediatric care.
Lopinavir/ritonavir for young infants
15 May 2005. Related: Conference reports, Paediatric care.
Paediatric dose finding atazanavir and atazanavir/ritonavir
15 May 2005. Related: Conference reports, Paediatric care.
Switching d4T to tenofovir and protease inhibitor to efavirenz
15 May 2005. Related: Conference reports, Paediatric care.
US guidelines on paediatric care updated (March 2005)
15 May 2005. Related: Paediatric care, Guidelines.
Paediatric care in lower income settings
18 April 2005. Related: Conference reports, Paediatric care.
Tenofovir not linked to bone toxicity in children followed for one year
18 April 2005. Related: Conference reports, Paediatric care.
Higher nevirapine doses for children leads to better outcome
29 March 2005. Related: Conference reports, Paediatric care.
Long-term response to FTC in children is similar to adults
29 January 2005. Related: Conference reports, Paediatric care.
CHIPS data finds response to HAART varies with age in children
6 November 2004. Related: Paediatric care.
HAART is effective in African children in a resource-limited setting
6 November 2004. Related: Paediatric care.
Predictive factors of virologic success in HIV positive children treated with lopinavir/ritonavir
6 November 2004. Related: Paediatric care.
Inventive ways to explain HAART and adherence to children
6 September 2004. Related: Conference reports, Paediatric care.
Isoniazid has early and unexpected benefit in reducing childhood mortality
6 September 2004. Related: Conference reports, Paediatric care.
Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with HIV
29 July 2004. Related: Paediatric care.
More positive children are surviving into adult life and require tailored services
2 June 2004. Related: Conference reports, Paediatric care.
Higher nelfinavir concentrations improve response in children
2 May 2004. Related: Conference reports, Paediatric care, PK and drug interactions.
PK of once daily lopinavir/r in children
2 May 2004. Related: Conference reports, Paediatric care, PK and drug interactions.
Children’s HIV National Network (CHINN) Review
2 May 2004. Related: Paediatric care.
FDA approves new paediatric dose of nelfinavir
2 May 2004. Related: Paediatric care.
Tenofovir studies in children
2 April 2004. Related: Conference reports, Paediatric care.
Should treatment be started in all newborns infected with HIV?
3 February 2004. Related: Paediatric care.
Tenofovir levels in children approach adult values
3 February 2004. Related: Paediatric care.
Study suggests paediatric dose of emtricitabine (FTC)
3 February 2004. Related: Paediatric care.
HIV production in children with “undetectable” viral load
3 February 2004. Related: Paediatric care.
Host genetic factors are important in disease progression in children
3 February 2004. Related: Paediatric care.
Dramatic decline in mortality, disease progression and hospital admissions in children with HIV infection in the UK and Ireland
1 December 2003. Related: Paediatric care.
New tool for assessing risks of disease progression and death based on age, CD4 percentage and viral load in HIV-infected children
1 December 2003. Related: Paediatric care.
Rituximab as single agent reversed paediatric Non-Hodgkins Lymphoma (NHL)
1 November 2003. Related: Paediatric care.
Perinatal antiretroviral treatment and haematopoiesis in HIV-uninfected infants
1 November 2003. Related: Paediatric care.
Higher than currently recommended NVP dose shows greater efficacy in HIV-infected children
1 October 2003. Related: Paediatric care.
Nevirapine and MTCT: the single-dose backlash
1 September 2003. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, Paediatric care.
Risk factors for paediatric HIV malignancies
1 July 2003. Related: Paediatric care, Cancer and HIV.
TREC analysis shows little thymic damage in HIV-positive adolescents
1 July 2003. Related: Paediatric care.
Metabolic abnormalities in protease inhibitor-treated and protease naïve children
1 July 2003. Related: Paediatric care, Lipodystrophy and metabolic complications.
Paediatrics: neurological and developmental outcomes
1 June 2003. Related: Conference reports, Paediatric care, Coinfections and complications.
Pediatric studies from 10th CROI
1 May 2003. Related: Conference reports, Women's health, Pregnancy, Paediatric care.
Adverse drug reactions and lipodystrophy in children
13 November 2002. Related: Conference reports, Paediatric care, Side effects.
Antiretrovirals have neurologic benefits in children
13 October 2002. Related: Paediatric care.
Early data highlight ribavirin’s anti-adenovirus potential
13 October 2002. Related: Paediatric care.
Four drug regimen for infants
11 September 2002. Related: Conference reports, Paediatric care.
Emergence of resistance in children treated with ddI/d4T after treatment to reduce MTCT
11 September 2002. Related: Conference reports, Paediatric care.
Increased risk of heart abnormalities in children born to mothers with HIV-1
11 September 2002. Related: Paediatric care.
Increased incidence of osteonecrosis of the hip observed in HIV-infected children
11 July 2002. Related: Paediatric care.
CCR5 density on CD4 cells governs course of HIV infection in children
11 June 2002. Related: Paediatric care.
Saquinavir is a suboptimal treatment for children unless used in combination
11 June 2002. Related: Paediatric care.
Mothers, orphans, and prevention of paediatric AIDS
11 May 2002. Related: Pregnancy, Paediatric care.
Birth defects linked to use of certain drugs during pregnancy
10 January 2002. Related: Paediatric care.
Immune reconstitution in children treated with HAART is independent of age and pre-treatment immune status
10 January 2002. Related: Paediatric care.
Lipodystrophy and metabolic changes in children
9 December 2001. Related: Conference reports, Paediatric care.
Syncytium inducing viral phenotype halves thymic T cell production in children
9 December 2001. Related: Paediatric care.
Children with advanced disease who take HAART experience immune reconstitution
9 December 2001. Related: Paediatric care.
EC approves abacavir for use by HIV-infected children
2 November 2001. Related: Antiretrovirals, Paediatric care.